I think the $117K of revenue out of this commercialisation in full year 2014 gives you a fair indication of what's happening out there. Sounds like yet another failed product as far as POH is concerned. I wouldn't be hanging my hat on this potential.
Voveran TPM vs voltaren, page-2
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40067123 | 32 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |